RHCGF OTC
Ryman Healthcare Limited
1W: +0.0%
1M: -24.3%
3M: +3.7%
YTD: -36.0%
1Y: -21.7%
3Y: -69.1%
5Y: -87.0%
$1.12
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$806M
+13.0% ▲
5Y CAGR: +12.3%
Gross Profit
-$18M
-102.5% ▼
Operating Income
-$18M
+84.8% ▲
Net Income
-$173M
+60.4% ▲
EPS (Diluted)
$-0.17
+72.1% ▲
EBITDA
$25M
+192.2% ▲
5Y CAGR: -44.2%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $504M | $560M | $651M | $714M | $806M |
| YoY Growth | +11.3% | +11.2% | +16.1% | +9.7% | +13.0% |
| Cost of Revenue | $502M | $580M | $652M | $0 | $824M |
| Gross Profit | $2M | -$20M | -$1M | $714M | -$18M |
| Gross Margin | 0.4% | -3.5% | -0.2% | 100.0% | -2.2% |
| R&D Expenses | $5M | $12M | $16M | $0 | $0 |
| SG&A Expenses | $306M | $177M | $464M | $544M | $0 |
| Operating Expenses | $710M | $216M | $720M | $832M | $0 |
| Operating Income | $2M | -$20M | -$70M | -$118M | -$18M |
| Operating Margin | 0.4% | -3.5% | -10.7% | -16.6% | -2.2% |
| Interest Expense | $31M | $120M | $50M | $140M | $120M |
| Income Before Tax | $722M | $206M | -$145M | -$215M | -$179M |
| Tax Expense | $29M | -$52M | -$150M | $221M | -$6M |
| Net Income | $693M | $258M | $5M | -$437M | -$173M |
| Net Margin | 137.5% | 46.0% | 0.7% | -61.2% | -21.5% |
| EPS (Diluted) | $1.31 | $0.50 | $0.01 | $-0.61 | $-0.17 |
| EBITDA | $788M | $458M | -$51M | -$27M | $25M |
| Shares Outstanding | 530M | 516M | 688M | 710M | 1.02B |